BRKR
Bruker Corporation
NASDAQ: BRKR · HEALTHCARE · MEDICAL DEVICES
$36.71
+7.06% today
Updated 2026-04-30
Market cap
$5.52B
P/E ratio
—
P/S ratio
1.61x
EPS (TTM)
$-0.15
Dividend yield
0.55%
52W range
$28 – $56
Volume
2.0M
Bruker Corporation (BRKR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $433.19M | $553.21M | $1.12B | $1.17B | $1.55B | $1.71B | $1.86B | $1.99B | $1.86B | $1.73B | $1.81B | $1.95B | $2.13B | $2.77B | $3.05B | $3.65B | $3.61B | $4.25B | $5.81B | $6.24B |
| Cash & equivalents | $52.15M | $72.88M | $166.20M | $207.10M | $230.40M | $246.00M | $310.60M | $438.70M | $319.50M | $267.10M | $342.40M | $325.00M | $322.40M | $678.30M | $681.80M | $1.07B | $645.50M | $488.30M | $183.40M | $298.80M |
| Current assets | $294.74M | $395.63M | $820.70M | $873.50M | $1.05B | $1.19B | $1.31B | $1.43B | $1.37B | $1.23B | $1.27B | $1.36B | $1.30B | $1.80B | $1.93B | $2.47B | $2.11B | $2.16B | $2.05B | $2.21B |
| Total liabilities | $241.48M | $294.02M | $803.60M | $753.20M | $1.02B | $1.09B | $1.15B | $1.14B | $1.09B | $998.00M | $1.12B | $1.22B | $1.22B | $1.83B | $2.07B | $2.57B | $2.48B | $2.84B | $3.99B | $3.73B |
| Current liabilities | $195.13M | $252.95M | $519.70M | $539.10M | $831.50M | $755.80M | $681.90M | $648.60M | $582.70M | $554.60M | $525.90M | $524.50M | $598.00M | $645.60M | $791.90M | $938.50M | $914.30M | $1.20B | $1.28B | $1.28B |
| Long-term debt | $22.86M | $6.39M | $182.80M | $115.70M | $86.60M | $219.40M | $335.90M | $354.30M | $354.20M | $265.20M | $391.60M | $415.60M | $322.60M | $812.80M | $842.30M | $1.22B | $1.20B | $1.16B | $2.06B | — |
| Shareholder equity | $191.47M | $258.66M | $311.90M | $418.80M | $527.40M | $624.90M | $706.60M | $850.20M | $771.70M | $732.90M | $693.10M | $733.50M | $905.10M | $906.80M | $961.20M | $1.07B | $1.11B | $1.38B | $1.78B | $2.47B |
| Retained earnings | $17.47M | $48.24M | $172.60M | $253.80M | $349.20M | $441.50M | $519.00M | $599.10M | $655.80M | $757.40M | $885.20M | $942.00M | $1.10B | $1.27B | $1.41B | $1.66B | $1.93B | $2.32B | $2.41B | — |
| Accounts receivable | $88.63M | $122.14M | $171.90M | $184.10M | $232.90M | $282.80M | $289.30M | $307.60M | $293.20M | $234.70M | $243.90M | $319.30M | $357.20M | $362.20M | $335.30M | $416.90M | $595.30M | $621.80M | $701.20M | $544.90M |
| Inventory | $134.50M | $171.33M | $425.10M | $422.80M | $511.00M | $576.20M | $611.50M | $589.80M | $477.40M | $422.00M | $440.40M | $486.20M | $509.60M | $577.20M | $692.30M | $710.10M | $800.10M | $968.30M | $1.07B | $1.09B |
| Goodwill | $39.78M | $40.78M | $46.40M | $47.50M | $98.30M | $100.20M | $115.90M | $127.40M | $127.80M | $130.60M | $130.60M | $169.80M | $275.70M | $293.00M | $320.40M | $339.50M | $457.60M | $582.60M | $1.51B | — |